ARCHIVES

Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

DRCCA Board Gives Concept Approval To Nutrition Clinical Trials Which Could Total $52.5 Million

January 28, 1983

Groups Advise NCI On “Investment Opportunities”

June 28, 1996

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

April 11, 2003

Funding Opportunities; Program Announcements Released By NCI

May 21, 1999